All News

Misinformation on YouTube promotes women wiping front to back as a non-evidence-based hygiene practice to prevent urinary tract infection.

The advent of pharmacy-based community health workers has helped to expand and codify the pre-existing community-based efforts of pharmacy technicians to reach even outside of medication access.

In addition to 2 FDA-approved options, several clinical trials are investigating other potential treatments for immunoglobulin A nephropathy.

Mendelian randomization makes it possible to infer if a drug target protein will have an on-target effect on disease-relevant traits.

Arexvy is the first respiratory syncytial virus (RSV) vaccine approved in the United States for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.

Asking pharmacists to do even more work while paring down their support is not a sustainable solution to increasing costs.

In addition to offering convenience and ease of access, Sullivan said allowing patients to receive care at home empowers them and improves quality of life.

A combination of cognitive behavioral therapy and medication had the most profound and stable result for patients suffering from insomnia.

Biosimilars are also expanding rapidly, offering new opportunities for payers, patients, and providers.

Panelists at AXS23 conference agree that the patient’s voice is the most critical, whether it is related to drug manufacturing, delivery, or marketing.

Studies show that patients who had pharmacists as part of their transplant-related care had a significant improvement in clinical outcomes.

Neutralizing monoclonal antibody therapies found to improve outcomes for unvaccinated and nonhospital patients at high risk of poor outcome for SARS-CoV-2.

Pharmacists will play a growing role in the use of biosimilars and guiding patients through the switching process.

Study shows eplontersen maintains a consistent and sustained treatment effect and reinforces its potential treating hereditary transthyretin-mediated amyloid polyneuropathy, which can lead to heart failure.

Immature data suggest enzalutamide combination improves overall survival in patients with high-risk biochemical recurrence.

Although these programs are not the entire solution to rising pharmacy costs, Marsh said they are an important part of solving the problem.

The COVID-19 pandemic revealed some of the major gaps in trust in the United States, but Johnson said pharmacists are key to improving it.

Recent editorial calls into question role, use of drug coverage for medications that often cost pennies to procure.

Health-system pharmacies should fight the well-orchestrated attempt to dismantle 340B drug pricing.

The law directs federal spending toward funding the internal revenue service, improving taxpayer compliance, lowering health care needs, and reducing carbon emissions.

The system is considered effective at identifying residual breast cancer following surgical resection.

An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.

The treatment showed significant improvement in patients in patients who require frequent blood transfusions and are at risk of infection.

Naveen Mansukhani, BPharm, discussed skyrocketing prices for specialty drugs and what is driving those increases.

Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the biosimilars landscape and where biosimilars fall in the process of pharmacy and medical benefit adoption.

Balancing clinicians’ priorities with the needs of patients and their families is crucial to ensure access and adherence to medications.

Cephalosporin treatment is a risk factor of Clostridioides difficile infection.

Screening tools are becoming widely used to help clinicians address the needs of patients with diabetes to improve health outcomes.

The final approval was based on efficacy and safety data from the phase 3 REST-ON study.

Molidustat oral suspension is also the first approval for cats under the FDA’s expanded conditional approval pathway.